RB
Rick Bienkowski Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Legend Biotech
LEGN
$6.41B
| $34.73 | $55 |
58%
upside
| Overweight |
14 May ‘25
3 months ago |
|
2
Beam Therapeutics
BEAM
$2.02B
| $19.92 | $39 |
96%
upside
| Outperform |
6 Nov ‘24
10 months ago |
|
3
Intellia Therapeutics
NTLA
$1.28B
| $11.92 | $65 |
445%
upside
| Overweight |
24 Jun ‘24
1 year ago |
|
4
Editas Medicine
EDIT
$254M
| $2.82 | $14 |
396%
upside
| Overweight |
13 Sep ‘23
2 years ago |
|
|
5
Beam Therapeutics
BEAM
$2.02B
| $19.92 | $113 |
467%
upside
| Outperform |
10 Aug ‘22
3 years ago |
|
6
CRISPR Therapeutics
CRSP
$4.98B
| $54.73 | $107 |
96%
upside
| Outperform |
8 Aug ‘22
3 years ago |
|
|
7
Editas Medicine
EDIT
$254M
| $2.82 | $27 |
857%
upside
| Market Perform |
25 Feb ‘22
3 years ago |
|